Uncover Your Pharmaceutical Value |info@vaultbio.com
LinkedInFacebookYouTubeInstagram

Pharma Industry News Weekly Recap: March 24, 2023

2023-03-24T09:29:37-07:004IR, adipose, AI, Alzheimer's, Biden, Biopharmaceutical Business Development, Cancer, Cardiovascular, Cell Therapy, COVID-19, Diabetes, Digital Health, Drug Discovery, Drug Pricing, FDA, Gene Therapy, Heart Failure, Industry News, Insulin, Medical Marijuana, Mergers, Obesity, Oncology, Opioids, Politics, Women's Health|

// Biotech and Pharma Therapeutics Novo Nordisk, Eli Lilly replenish Type 2 diabetes stars Ozempic, Mounjaro after off-label [...]

Read More

Pharma Industry News Weekly Recap: March 17, 2023

2023-03-17T09:37:56-07:004IR, adipose, AI, Alzheimer's, Biden, Biopharmaceutical Business Development, Cancer, Cardiovascular, Cell Therapy, COVID-19, Diabetes, Digital Health, Drug Discovery, Drug Pricing, FDA, Gene Therapy, Heart Failure, Industry News, Insulin, Medical Marijuana, Mergers, Obesity, Oncology, Opioids, Politics, Women's Health|

// Biotech and Pharma Therapeutics Novo Nordisk follows Eli Lilly's lead, slashing insulin prices in the US March [...]

Read More

Pharma Industry News Weekly Recap: March 10, 2023

2023-03-10T10:50:08-07:003D Printing, 4IR, adipose, AI, Alzheimer's, Biden, Biopharmaceutical Business Development, Cancer, Cardiovascular, Cell Therapy, COVID-19, Diabetes, Digital Health, Drug Discovery, Drug Pricing, FDA, Gene Therapy, Heart Failure, Industry News, Insulin, Medical Marijuana, Mergers, Obesity, Oncology, Opioids, Politics, Women's Health|

// Biotech and Pharma Therapeutics With PCSK9 pill, Merck aims to succeed where others failed March 7, 2023 / [...]

Read More

Pharma Industry News Weekly Recap: March 3, 2023

2023-03-03T10:18:48-07:003D Printing, 4IR, adipose, AI, Alzheimer's, Biden, Biopharmaceutical Business Development, Cancer, Cardiovascular, Cell Therapy, COVID-19, Diabetes, Digital Health, Drug Discovery, Drug Pricing, FDA, Gene Therapy, Heart Failure, Industry News, Insulin, Medical Marijuana, Mergers, Obesity, Oncology, Opioids, Politics, Women's Health|

// Biotech and Pharma Therapeutics After spending $6.5B for Momenta, J&J readies 'pipeline in a product' for pivotal year [...]

Read More

Biogen And Eisai Say Alzheimer’s Drug A Success, Encouraging Phase II Results in Alzheimer’s Disease

2020-08-17T20:53:26-07:00Industry News|

A complicated new clinical trial could give some hope to Alzheimer’s patients and investors in drug companies. But there are [...]

Read More
Go to Top